Literature DB >> 32045373

Characterization of uropathogenic ESBL-producing Escherichia coli isolated from hospitalized patients in western Algeria.

Fatima Zenati1, Abouddihaj Barguigua2, Kaotar Nayme3, Fethi Benbelaïd4, Abdelmounaïm Khadir5, Chafika Bellahsene6, Mourad Bendahou7, Hassaïne Hafida8, Mohammed Timinouni9.   

Abstract

INTRODUCTION: The aim of this study is to assess the prevalence and molecular characterization of uropathogenic Extended spectrum β-lactamases (ESBLs) producing Escherichia coli.
METHODOLOGY: During 3 years, all hospitalized patients at the University-affiliated hospital of Tlemcen and presenting urinary tract infections caused by E. coli were considered as potential study participants. These E. coli isolates were examined phenotypically for ESBL production. ESBL strains were subjected to antimicrobial susceptibility testing and were investigated for the presence of plasmid mediated quinolone resistance genes, 16SrRNA methylase genes and virulence genes by using conventional PCR and DNA sequencing. The molecular characterization of ESBL strains was established by phylogenetic grouping method and ERIC-PCR.
RESULTS: The overall prevalence of ESBL was 32.5%. The blaCTX-M-15 was the most frequently detected in ESBL isolates, followed by blaCTX-M-14, blaCTX-M-28, blaCTX-M-1 and blaSHV-12 respectively. The plasmid-mediated quinolone resistance genes were detected in the 15 ESBL strains with the aac(6')-Ib-cr gene was the most detected followed by qnrB1 and qnrA1 gene respectively. Among the 22 ESBL isolates resistant to gentamicin and amikacin, the 16SrRNA methylase genes were detected in 4 isolates. The sfa and pap virulent genes were founds in 26% and 22% of isolates receptively. The genotyping analysis of all strains revealed that almost were belonged to phylogenetic groups A1 and A0 and fourteen distinct clones.
CONCLUSION: The emergence of uropathogenic ESBL isolates and the high rate of blaCTX-M are alarming in Algeria. Strict measure must be required to control the further spread of these strains in Algerian hospitals. Copyright (c) 2019 Mohammed Timinouni, Abouddihaj Barguigua, Fethi Benbelaïd, Kaotar Nayme, Fatima Zenati, Abdelmounaïm Khadir, Chafika Bellahsene, Mourad Bendahou, Hassaïne Hafida.

Entities:  

Keywords:  E.coli; ESBL; Escherichia coli; Extended-spectrum β-lactamase; UTI; Urinary tract infections

Mesh:

Substances:

Year:  2019        PMID: 32045373     DOI: 10.3855/jidc.10702

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  2 in total

1.  Expanded validation of the effect and quality of a pathogen inactivation system based on riboflavin photochemistry on platelet bacterial contamination.

Authors:  Bin Fan; Meng Yi; Guang Yang; Lu Yang; Wei Shang; Yi Liu; Xiaolong Zhong; Liguo Zhu; Deqing Wang
Journal:  Ann Transl Med       Date:  2021-12

2.  High levels of gut carriage of antimicrobial-resistant Escherichia coli in community settings in Rio de Janeiro, Brazil.

Authors:  Káris Maria de Pinho Rodrigues; Danielle Ferreira de Rezende; Michelle Pessanha Pinto; Samantha Dos Santos Tufic-Garutti; João Vitor Almeida Ramalho; Luís Guilherme de Araújo Longo; Valéria Brígido de Carvalho Girão; Gabriela Caramano de Oliveira; Lucas Cecílio Vilar; Beatriz Meurer Moreira
Journal:  Braz J Microbiol       Date:  2022-01-06       Impact factor: 2.476

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.